Checkpoint Therapeutics, Inc.
CKPT
$4.04
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.60M | 4.70M | 4.95M | 11.24M | 4.93M |
| Total Receivables | -- | -- | 41.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 867.00K | 476.00K | 678.00K | 734.00K | 450.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.47M | 5.18M | 5.67M | 11.98M | 5.38M |
|
|
|||||
| Total Current Assets | 7.47M | 5.18M | 5.67M | 11.98M | 5.38M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.47M | 5.18M | 5.67M | 11.98M | 5.38M |
|
|
|||||
| Total Accounts Payable | 6.09M | 7.89M | 10.84M | 11.92M | 6.57M |
| Total Accrued Expenses | 12.35M | 9.53M | 10.19M | 9.59M | 11.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.66M | 348.00K | 390.00K | 708.00K | 711.00K |
| Total Other Current Liabilities | 1.66M | 348.00K | 390.00K | 708.00K | 711.00K |
| Total Current Liabilities | 20.10M | 17.77M | 21.42M | 22.23M | 18.43M |
|
|
|||||
| Total Current Liabilities | 20.10M | 17.77M | 21.42M | 22.23M | 18.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.10M | 17.77M | 21.42M | 22.23M | 18.43M |
|
|
|||||
| Common Stock & APIC | 350.31M | 329.08M | 316.20M | 311.61M | 297.87M |
| Retained Earnings | -370.57M | -341.67M | -331.95M | -325.28M | -314.33M |
| Treasury Stock & Other | 7.64M | -- | -- | 3.42M | 3.42M |
| Total Common Equity | -12.63M | -12.59M | -15.75M | -10.25M | -13.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.63M | -12.59M | -15.75M | -10.25M | -13.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.63M | -12.59M | -15.75M | -10.25M | -13.05M |
|
|
|||||